KFSHRC receives Italy's Health Minister, highlights medical advancements
H.E. was welcomed by Dr. Björn Zoëga, Deputy Chief Executive Officer of KFSHRC. The visit featured a comprehensive briefing on the Heart Centre of Excellence and the Organ Transplant Centre of Excellence, along with an overview of the latest technologies used in treating complex cardiac conditions and performing minimally invasive robotic surgeries. These innovations have significantly reduced complications, accelerated recovery, and lowered healthcare costs.
This visit reflects the growing global interest in KFSHRC's pioneering model, which integrates deep clinical expertise with cutting-edge medical technologies. The hospital has achieved several historic milestones, including the world's first fully robotic heart transplant and the first fully robotic liver transplant. These breakthroughs reinforce its standing as a global reference in advanced specialized care.
It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
5 days ago
- Zawya
KFSHRC performs world's first robotic-assisted BiVAD Implantation
A minimally invasive robotic surgery offers a life-saving option for high-risk patients who cannot undergo transplants or traditional open-heart procedures King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world's first implantation of two artificial pumps for biventricular support (BiVAD-HMIII) using robotic technology on a patient with advanced heart failure. This groundbreaking procedure opens new horizons in circulatory support techniques for patients with complex cardiac conditions and marks a medical achievement that culminated in the patient's recovery within a short period following the surgery. The procedure represents a major advancement in the treatment of bilateral heart failure, which was traditionally performed through full sternotomy, an approach associated with higher surgical risks and prolonged recovery. However, the cardiac surgery team at KFSHRC, led by Prof. Feras Khaliel, successfully performed the operation through small incisions using remotely controlled high-precision robotic arms, resulting in reduced blood loss, lower risk of infection, and faster patient recovery. The 61-year-old patient was admitted after spending over two months bedridden, suffering from end-stage heart failure unresponsive to medical therapy, in addition to multiple chronic conditions including diabetes, stroke, and renal impairment. After a comprehensive clinical evaluation, the patient was deemed ineligible for a heart transplant, making robotic implantation of the artificial pumps a vital and unique solution suited to his health status. This milestone reflects the integration of expertise across multiple departments at KFSHRC including cardiac surgery, cardiology, anesthesia, critical care, biomedical engineering, and advanced life support. The procedure was meticulously planned and benefited from 3D imaging technologies, real-time surgical navigation, and innovative solutions for safely securing the mechanical assist devices. KFSHRC aims to publish the results of this procedure in peer-reviewed medical journals and present them at global cardiology conferences to promote knowledge exchange and establish innovative partnerships with leading international centers in robotic care and advanced heart failure management. This achievement adds to KFSHRC's track record in robotic surgery which includes the world's first fully robotic heart transplant and the World's First Robotic-Assisted Artificial Heart Pump Implantation. These milestones serve as evidence of its leadership in adopting cutting-edge cardiac technologies and managing critical conditions with the highest standards of precision and safety, further reinforcing its position as a leading academic medical center both regionally and globally. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Emirates 24/7
6 days ago
- Emirates 24/7
Dubai Media and Dubai Quality Group Sign Strategic Partnership to Advance a Culture of Excellence in Media
In alignment with Dubai Quality Group's vision to promote a culture of quality, institutional excellence, and innovation across UAE institutions, a strategic Memorandum of Understanding has been signed with Dubai Media to foster collaboration and strengthen the efforts of both organizations. The partnership aims to create an interactive platform that connects decision-makers and quality experts at local and global levels, enabling the exchange of best practices in institutional excellence, women empowerment, innovation, technology, and artificial intelligence—while supporting Dubai Media's goal of embedding a culture of quality in the media sector. The MoU was signed by Dr. Maitha Buhumaid, CEO of Marketing and Communication at Dubai Media, and Samira Mohammed, Managing Director of Dubai Quality Group, reaffirming both sides' commitment to supporting the UAE's visionary leadership and raising awareness about the importance of institutional quality in public and private sectors. The agreement enables Dubai Media to participate in several high-profile awards by Dubai Quality Group, such as the Emirates Women Award, UAE Innovation Award, Ideas Arabia International Award, UAE Ideas Award, Global AI Award, Global Continuous Improvement Award, and Global Medical Excellence Award. Dubai Media will also benefit from advisory services and capacity-building programs in enterprise risk management, Lean Six Sigma (a structured management approach that improves efficiency and quality), and business continuity. The agreement also grants access to benchmarking tools and best practice sharing with top-performing entities across the public and private sectors—fostering a culture of professional growth and operational excellence. Dr. Maitha Buhumaid emphasized Dubai Media's commitment to adopting world-class systems and innovative methodologies to strengthen its institutional performance and competitiveness. She stated: "Dubai Media is committed to adopting innovative solutions, advanced management systems, and internationally recognized quality standards to strengthen our institutional capabilities and accelerate operational excellence. This partnership supports our strategic vision to position Dubai as a global hub for media production and content leadership, while investing in talent development and fostering a culture of innovation and continuous improvement." Samira Mohammed, Managing Director of Dubai Quality Group, added: "We are proud of this strategic partnership with Dubai Media, which reflects the culmination of both organizations' efforts toward excellence. This collaboration marks a valuable addition to the Group's initiatives and supports our journey to embed global standards of quality, institutional excellence, innovation, and digital transformation in the UAE. We are committed to forging more strategic alliances that reinforce the UAE's global competitiveness and sustainable growth, while offering greater value to the national business ecosystem."
Web Release
09-07-2025
- Web Release
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition. When the early signs of illness appeared during the patient's first months of life, KFSHRC teams raced against time to stabilize her condition. She was diagnosed with a congenital deficiency in plasminogen, a protein essential for dissolving blood clots, resulting in fibrous deposits that posed serious threats to her tissues and organs. The complexity of her case posed both medical and quality-of-life challenges, requiring a comprehensive, multidisciplinary care system. This extended beyond medical treatment to include all facets of life-supporting care. Teams from nursing, nutrition, and information technology joined hematology and transplant specialists to ensure the young girl's well-being. In a reflection on the early days, the patient's father said: 'My daughter suffered from the moment she was born. She cried constantly and couldn't nurse. We lived in continuous worry with no clear answers until God opened a door of hope. Today, thanks to God first, and then to the remarkable healthcare capabilities provided by the Government of the Custodian of the Two Holy Mosques and His Royal Highness the Crown Prince, may God preserve them, we witness our daughter's recovery from this rare disease after two decades of struggle.' Throughout the years of treatment, the patient relied on regular intravenous doses of plasminogen, along with eye drops to reduce the disease's effect on her vision. The annual cost of treatment exceeded 6 million SAR, fully covered by the Saudi government. This reflects the Kingdom's profound commitment to human health and its investment in quality of life even in the most complex medical cases. Dr. Hazzaa Al-Zahrani, Director of Adult Hematology and Stem Cell Transplant Division at KFSHRC Riyadh and the supervising physician, explained that managing the case required a precise and long-term approach to prevent complications and ensure stability. The decision to proceed with a liver transplant came after careful consideration as an extraordinary therapeutic option for an exceptionally rare case. The success of the procedure marked a turning point in her medical journey and a beacon of hope for patients facing similar conditions worldwide. This approach is deeply rooted in the vision of King Faisal Specialist Hospital & Research Centre, which places the patient at the core of every practice and is committed to delivering integrated care where scientific expertise meets human compassion, in line with its mission to serve society at the highest standards. For more information, visit or contact our media team at [email protected]
